Publications in collaboration with researchers from Centro Nacional de Investigaciones Oncológicas (9)

2022

  1. Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice

    Blood, Vol. 139, Núm. 2, pp. 228-239

  2. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75

2018

  1. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 16, pp. E3769-E3778

2014

  1. Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation

    Cancer Research, Vol. 74, Núm. 13, pp. 3512-3524

  2. Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer

    Journal of Pathology, Vol. 234, Núm. 2, pp. 214-227

2012

  1. Key contribution of CPEB4mediated translational control to cancer progression

    Nature Medicine, Vol. 18, Núm. 1, pp. 83-90

2009

  1. FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Núm. 7, pp. 1156-1166

  2. Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic Cancer

    Gastroenterology, Vol. 136, Núm. 4

2008

  1. Pancreatic ductal adenocarcinoma: Cellular origin, signaling pathways and stroma contribution

    Pancreatology, Vol. 8, Núm. 4-5, pp. 462-469